Life Sciences

Alzheon, a Framingham-based biopharmaceutical company, has promoted Glenn Pauly to chief commercial officer and appointed two new vice presidents.

Chicago-based biotech giant AbbVie, which has a large bioresearch facility in Worcester, will acquire Waltham’s ImmunoGen and its flagship ovarian cancer treatment drug in an more than $10-billion transaction.

Psychemedics, an Acton-based manufacturer of drug testing kits, has hired Daniella Mehalik as the company’s vice president of finance.

Companies must expand their networks & standardize processes to meet diversity, equity, and inclusion targets.

Following a $2.1-million loss in the third quarter, Acton drug testing firm Psychemedics said on Thursday it is in the midst of a restructuring.

Marlborough biopharma firm Phio Pharmaceuticals has enrolled its first patient in a clinical trial, entering the next phase of its strategic plan to move into the clinical development space.

Dean College, a private college located in Franklin, is using a $600,000 grant from the Massachusetts Life Sciences Center in Waltham to fund new scientific equipment.

United Medical Systems, a Westborough-based provider of mobile urology services to hospitals, has named Matthew Gattuso as the company’s new president.

Worcester life sciences incubator Massachusetts Biomedical Initiatives has awarded seven grants to local individuals and companies as part of its 2023 Challenge Grants program.

Key players in the Central Mass. life science ecosystem are taking on a new initiative to help launch Worcester to the forefront of bioindustrial manufacturing.